Nyvepria (pegfilgrastim)

pCPA File Number: 21350
Negotiation Status:
Concluded with an LOI
Indication(s):
febrile neutropenia in non-myeloid malignancies
Sponsor/Manufacturer:
Pfizer Canada Inc.
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: